Development trend of pharmacies in China

In 20 10, the proportion of chain pharmacies in China was only 34.34%, and it increased to 55.34% in 20 19. There are two reasons for the annual increase. First, from the perspective of government supervision, supervision will continue to be stricter, and punishment will increase the cost of small and medium-sized pharmacies; Under the influence of policies such as quantity purchasing, the bargaining power of small and medium-sized pharmacies is weak, and the growth rate of the same store is even negative. Secondly, chain retail enterprises generally have the competitive advantages of strong capital strength, fine management and strong bargaining power, and are ahead of other small and medium-sized pharmacies in licensed pharmacists, capital, manufacturer resources and supply chain capabilities.

Development trend 1: the speed of mergers and acquisitions is accelerating.

The rising cost of expansion promotes the concentration of advantages of head enterprises, and the development ceilings of small and medium-sized chain stores and individual pharmacies are obvious, and the industry will usher in a rapid increase in concentration. Judging from the overall growth of more than 20% of listed retail pharmacies, the increase of concentration is the core factor of the growth of retail pharmacy industry. Compared with the United States and Japan, the concentration of China's pharmaceutical retail industry is relatively low, and the United States ranks first in 20 19.

The number of pharmacies owned by chain pharmacies exceeds 30%, contributing more than 80% of sales. The sales of Japanese TOP 10 chain pharmacies account for 70% of the industry market share.

On the other hand, China, 20 19 China TOP.

10 chain pharmacies only account for 9.3% of the total number of pharmacies, and sales only account for 22%. Therefore, there is still a huge room for improvement in the concentration of the pharmaceutical retail industry in China. With the increasingly standardized management of taxation and food and drug supervision, the concentration of the industry has increased, and small and medium-sized chain pharmacies have been integrated by chain head enterprises with standardized operations, so the pharmaceutical retail industry will be more standardized and promote the healthy development of the industry.

Development trend 2: accelerate online layout

According to the data of our website, the sales scale of physical pharmacies and online pharmacies (including drugs and non-drugs) reached 662 billion yuan in 20 19, in which the sales scale of physical pharmacies decreased year by year, with the growth rate of 3.23% in 20 19; Online pharmacies have developed rapidly, and the sales scale has increased from 1. 18% in 20 19 to 18.90% in 20 19, and from 20 13 to 20/kloc-0. It can be seen that the e-commerce business has had a certain impact on the sales of offline stores, and in the future, with the promotion of regulatory policies, technological progress and further changes in consumer consumption habits, small and medium-sized pharmacies that have not yet laid out medical e-commerce will be more affected.

B2C third-party platform is still the main channel for medical e-commerce, including Tmall Medical Museum, JD.COM Medical Museum, Pinduoduo, pharmacy online mall, etc. By 2020, the four platforms will have 578, 602,114 and 1382 online pharmacies respectively. The products of B2C platform are mainly drugs, among which the drugs in Tmall Medical Museum account for 69.25%, and those in JD.COM Mall account for 78.59%.

Under the situation that online stores are facing a decline in gross profit margin and passenger flow, retail pharmacies should actively deploy online business, explore more business opportunities in four major scenarios, such as medical consultation, remote diagnosis and treatment, online drug purchase and health management, broaden business areas, and take online traffic as offline diversion, and finally form online+offline closed-loop development.

-For more research and analysis of this industry, please refer to the Analysis Report on Market Foresight and Investment Strategic Planning of Chain Pharmacy Industry in China by Forward-looking Industry Research Institute.